Utah Medical Products - 19 Year Stock Price History | UTMD

Historical daily share prices for Utah Medical Products since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Utah Medical Products as of August 16, 2018 is 87.15.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.335B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $123.073B 19.05
Abbott Laboratories (ABT) United States $111.627B 23.39
Stryker (SYK) United States $62.161B 24.02
Boston Scientific (BSX) United States $46.605B 24.25
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.903B 16.00
Smith & Nephew SNATS (SNN) United Kingdom $15.491B 0.00
ResMed (RMD) United States $15.453B 30.67
Bio-Rad Laboratories (BIO) United States $9.687B 62.27
Perrigo (PRGO) Ireland $9.503B 13.48
Hill-Rom Holdings (HRC) United States $6.289B 21.33
ICU Medical (ICUI) United States $6.001B 40.67
Canopy Growth (CGC) Canada $5.429B 0.00
Haemonetics (HAE) United States $5.340B 48.73
Insulet (PODD) United States $5.133B 0.00
Agios Pharmaceuticals (AGIO) United States $4.525B 0.00
Neogen (NEOG) United States $4.386B 69.89
Hutchison China MediTech (HCM) China $4.128B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.707B 0.00
NuVasive (NUVA) United States $3.433B 32.57
National Vision Holdings (EYE) United States $3.287B 72.72
Quidel (QDEL) United States $2.771B 56.77
Phibro Animal Health (PAHC) United States $2.014B 29.91
NxStage Medical (NXTM) United States $1.858B 0.00
Cardiovascular Systems (CSII) United States $1.239B 745.00
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.27
VAREX IMAGING (VREX) United States $1.118B 18.26
AtriCure (ATRC) United States $1.092B 0.00
Omeros (OMER) United States $1.001B 0.00
Orthofix (OFIX) United States $1.001B 30.48
OraSure Technologies (OSUR) United States $0.995B 65.08
TG Therapeutics (TGTX) United States $0.977B 0.00
Surmodics (SRDX) United States $0.976B 117.90
Cerus (CERS) United States $0.974B 0.00
Owens & Minor (OMI) United States $0.947B 10.13
MacroGenics (MGNX) United States $0.866B 0.00
LeMaitre Vascular (LMAT) United States $0.707B 33.91
PetIQ (PETQ) United States $0.694B 23.76
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.560B 0.00
Evolus (EOLS) United States $0.530B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.337B 0.00
Quanterix (QTRX) United States $0.315B 0.00
Surface Oncology (SURF) United States $0.275B 0.00
Rockwell Medical (RMTI) United States $0.245B 0.00
Chimerix (CMRX) United States $0.202B 0.00
Fonar (FONR) United States $0.170B 10.32
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.156B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.120B 0.00
Female Health (VERU) United States $0.109B 0.00
Trinity Biotech (TRIB) Ireland $0.091B 27.13
Oramed Pharmaceuticals (ORMP) Israel $0.087B 0.00
United-Guardian (UG) United States $0.086B 18.94
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.076B 0.00
CAS Medical Systems (CASM) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Akers Biosciences Inc (AKER) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00